Table 3 EC50 values of compounds with good antibacterial activities against Xoo and Xac.a

From: Organocatalytic iminium-assisted asymmetric B(sp²)-to-B(sp³) transformation

Compound

EC50 of Xoo (μg / mL)a

Compound

EC50 of Xac (μg / mL)a

(Rac)-3k

118.76 ± 0.79

(Rac)-3b

97.72 ± 1.43

(R)-3k

107.77 ± 1.93

(R)-3b

135.37 ± 3.07

(S)-3k

38.53 ± 2.45

(S)-3b

31.36 ± 2.57

(Rac)-4i

196.32 ± 2.47

(Rac)-4d

92.53 ± 2.08

(R)-4i

47.57 ± 3.81

(R)-4d

168.26 ± 1.73

(S)-4i

182.05 ± 4.19

(S)-4d

43.64 ± 1.37

(Rac)-4j

73.99 ± 2.03

(Rac)-4j

60.88 ± 3.68

(R)-4j

24.97 ± 1.69

(R)-4j

143.27 ± 2.53

(S)-4j

88.94 ± 2.13

(S)-4j

38.66 ± 1.72

BTb

53.95 ± 3.58

BTb

46.81 ± 1.34

TCc

40.18 ± 2.48

TCc

56.42 ± 4.43

  1. aAll data were average data of three replicates. bBT bismerthiazol, cTC thiodiazole copper.